Breaking News
March 19, 2019 - Use of synthetic psychedelic linked to improvements in depression and anxiety
March 19, 2019 - Knee Pain Not Tied to Activity Levels in Knee Osteoarthritis
March 19, 2019 - Study shows benefits of delayed cord clamping in healthy babies
March 19, 2019 - A cell’s “self-destruct” function could yield new therapies
March 19, 2019 - Latest advances and perspectives of all AI types used in pharmaceutical R&D
March 19, 2019 - Prophylactic cranial irradiation used as standard approach for patients with NSCLC
March 19, 2019 - Sugar-sweetened beverages may be linked with increased risk of cardiovascular mortality
March 19, 2019 - AHA News: Black Woman in Their 50s Face Especially High Stroke Risk
March 19, 2019 - Secrets of early life revealed from less than half a teaspoon of blood
March 19, 2019 - Immune cells engineered to tattle on suspicious cells in the body
March 19, 2019 - Heart attack patients who are taken to heart care centres directly survive longer
March 19, 2019 - IVF babies have increased in birthweight over the past 25 years, study reveals
March 19, 2019 - Study highlights the need for psychiatric care to be integrated into cancer treatment
March 19, 2019 - Testosterone treatment lowers recurrence rates in low-risk prostate cancer patients
March 19, 2019 - Caterpillars could hold the secret to new treatment for Osteoarthritis
March 19, 2019 - Parkinson’s treatment delivers a power-up to brain cell ‘batteries’
March 19, 2019 - Stanford launches new Institute for Human-Centered Artificial Intelligence
March 19, 2019 - Wireless earphones may cause cancer
March 18, 2019 - ACC/AHA guideline for prevention of cardiovascular disease released
March 18, 2019 - UTA nursing professor receives $6.575 million to attack musculoskeletal diseases
March 18, 2019 - Gene medication shows promise to treat spinal cord injuries
March 18, 2019 - First Human Study of “Robotic” RaniPill™ Capsule to Replace Injections Announced by Rani Therapeutics
March 18, 2019 - Food Allergy Testing: MedlinePlus Lab Test Information
March 18, 2019 - Altered brain activity patterns of Parkinson’s captured in mice
March 18, 2019 - Apple Heart Study demonstrates ability of wearable technology to detect atrial fibrillation | News Center
March 18, 2019 - Cardiovascular benefits of diabetes drug extend across a wide spectrum of patients, shows study
March 18, 2019 - Novel cardiac pump shows superior outcomes in patients with advanced heart failure
March 18, 2019 - U.S. FDA Grants Priority Review for Fedratinib New Drug Application in Myelofibrosis
March 18, 2019 - Living like a caveman won’t make you thin—but it might make you healthy
March 18, 2019 - Modified immune cells issue alert when detecting cancer in mice | News Center
March 18, 2019 - Dementia caregivers design robots for alleviating stress and increasing joyful moments
March 18, 2019 - VR technology could help improve balance in humans
March 18, 2019 - Study demonstrates effective way to slow progression of cerebrovascular disease in older adults
March 18, 2019 - Premature babies also have protective anti-viral antibodies
March 18, 2019 - Painkillers taken by pregnant mothers unlikely to cause asthma in the child
March 18, 2019 - Fibromyalgia can be reliably detected in blood samples
March 18, 2019 - Marijuana use has dropped among most teens after legalization
March 18, 2019 - Legacy Pharmaceutical Packaging, LLC Issues Voluntary Nationwide Recall of Losartan Potassium Tablets, USP, 25mg, 50mg, And 100mg Due to The Detection of Trace Amounts Of N-Nitroso N-Methyl 4-Amino Butyric Acid (NMBA) Impurity Found in The Active Pharmaceutical Ingredient (API)
March 18, 2019 - Researchers identify early home and family factors that contribute to obesity
March 18, 2019 - Fate and festivity: Match Day 2019
March 18, 2019 - Study finds TAVR to be as good as open-heart surgery for patients at low surgical risk
March 18, 2019 - EU-funded project is developing new tools for diagnosing cancer
March 18, 2019 - Gluten, lactose, food dyes in pills could be causing side effects finds study
March 18, 2019 - Taking painkillers during pregnancy is not responsible for asthma risk in children, study shows
March 18, 2019 - Prediagnosis Psychiatric Care Linked to Worse Cancer Mortality
March 18, 2019 - Paris hospital halts stool study after donor deluge
March 18, 2019 - Partial oral antibiotic therapy shows efficacy and safety in patients with infectious endocarditis
March 18, 2019 - Olympus improves access to science education through BioBus collaboration
March 18, 2019 - Depression screening does not improve quality of life in heart attack patients
March 18, 2019 - Echocardiography may aid in patient selection for TMVR
March 18, 2019 - Are ‘Inactive’ Ingredients in Your Drugs Really So Harmless?
March 18, 2019 - Wearable technology can safely identify atrial fibrillation
March 18, 2019 - Scientists tackle rare retinal disease in unique research project
March 18, 2019 - Death By A Thousand Clicks
March 18, 2019 - Absorbable, antibiotic-eluting envelope can reduce rate of cardiac device infections
March 18, 2019 - Hormonal treatment associated with depression in men with prostate cancer
March 18, 2019 - Porvair Sciences launches reinforced 96-well deep round microplate
March 18, 2019 - Simplified catheter ablation could slash waiting lists for atrial fibrillation patients
March 18, 2019 - BFR therapy as part of rehabilitation following ACL surgery may slow bone loss
March 18, 2019 - A human model to test implants for cataract surgery
March 18, 2019 - New risk adjustment model could reduce financial penalty for safety net hospitals
March 18, 2019 - NHS cancer patients’ wait to start treatment worrying
March 18, 2019 - Inventiva Announces Results from Phase IIb Clinical Trial with Lanifibranor in Systemic Sclerosis
March 18, 2019 - Cologuard
March 18, 2019 - Researchers find evidence of prenatal environment tuning genomic imprinting
March 18, 2019 - Dolomite Bio launches novel Nadia product family for single-cell research
March 18, 2019 - Intellipharmaceutics Announces Resubmission of New Drug Application to the U.S. FDA for its Oxycodone ER
March 18, 2019 - Excessive gestational weight gain tied to maternal morbidity
March 18, 2019 - RCEM issues position statement on metrics to supplement four-hour standard target
March 17, 2019 - Noncontrast Brain MRI Effective for Monitoring Multiple Sclerosis
March 17, 2019 - Brain region plays key role in regulation of parenting behavior, study finds
March 17, 2019 - Natural speed limit on DNA replication sets pace for life’s first steps
March 17, 2019 - New research reveals overlooked impact of herbicide glyphosate on the environment
March 17, 2019 - Molecular patterns could help predict relapse risk in breast cancer patients
March 17, 2019 - Study confirms sensitivity of microbiological cultures for detecting cholera
March 17, 2019 - Scientists Spot Clues to Predicting Breast Cancer’s Return
March 17, 2019 - Scientists identify gene that keeps PTSD-like behavior at bay in female mice
March 17, 2019 - New method would allow doctors to detect earliest stages of cancers in the lymph nodes
March 17, 2019 - Cholesterol protein discovery raises hope for smarter drugs
March 17, 2019 - New insect medium delivers high viable cell density growth and protein yield
Samara scholars assessed a new way of skin cancer early diagnostics

Samara scholars assessed a new way of skin cancer early diagnostics

image_pdfDownload PDFimage_print

A team of scholars of Samara National Research University and Samara State Medical University as well as clinic specialists of Samara Regional Oncology Centre (SROC) tested a new way of skin cancer early diagnostics with the help of original complex of three devices.

The efficiency of oncology treatment is directly connected with the timeliness of their detection. For instance, for melanoma – the most aggressive form of skin tumor detected at the first stage – five-year survival rate after the treatment makes 98% and does not exceed 15% with diagnostics at the fourth stage.

Methods created by the team of Samara scholars allowed enhancing the efficiency of active and early skin neoplasm diagnostics up to 97% when the exactness of usual standard clinical research does not exceed 50-60%.

The research results are given in the article “Combined Raman and autofluorescence ex vivo diagnostics of skin cancer in NIR and visible regions” which was published in one of the most authoritative journals devoted to the use of modern optical technology for research in Medicine and Biology – Journal of Biomedical Optics.

In the basis of methodology developed by Samara scholars at the Department of Laser and Biotechnical Systems of Samara University (headed by professor Valeriy Zakharov) is a system of spectral measurement of problem skin areas with the further medical interpretation of the received data offered by the Department of Oncology of SSMU (headed by professor Sergey Kozlov).

As professor Zakharov explained the developed system of spectral measurement allows registering parameters of a patient’s skin in many spectral ranges simultaneously and this gives opportunity to spot pathological changes on cell level as ill cells in their range are different from the healthy ones.

This means is the most suitable for screening programmes: not only it allows diagnosing pathology rather precisely and quickly, but it also does not require any use of additional consumable materials and chemical agents and permits to do without the use of invasive method of diagnosis confirmation. “For example, in case of suspicion in skin melanoma incorrect biopsy of a tumour increases the risk of metastasis”, – Alexander Moryatov, the curator of the project, associate professor of the department of Oncology of SSMU added. – In any case after examination of a patient and surgical treatment we finally confirm the diagnosis morphologically”.

The scholars use three devices for diagnostics.

The first one is an experimental setting for measurement of Raman scattering, it studies spectral characteristics of neoplasms, first of all, skin melanoma. According to Sergey Kozlov this device is suitable for precise diagnostics of a malignant tumor nature allowing to diagnose and differentiate between melanoma and other forms of skin tumor quickly and safely. “This setting can be set in an ordinary regional hospital”, – the professor specified.

The second device – dermatoscope – gives a visual picture of tumor with the maximum approach to its surface and allows seeing and fixing characteristic signs of this disease in real time. According to Sergey Kozlov this device can be compared favorably with the similar ones in respect of a user-friendly interface, the ability to conduct analysis in the mode of polarized light, as well as with the help of special highlight to study peculiarities of melanin, hemoglobin, structure of capillary network in the studied skin area.

The third – hyperspectral camera – allows in a short period of time to make several tens of shots in different ranges (for different skin neoplasms are characteristic different optical characteristics) with high definition.

All three devices represent a joint development of Samara University scholars, SSMU and SROC and are directed at comparative research of optical characteristics of healthy and pathologically changed tissues in which analysis of different types of neoplasms is built on the basis of joint interpretation of their ranges got with the application of completely safe technologies and laser light sources of different wavelengths.

It is said about two types of spectral analysis the character of which depends on biochemical composition of tissues under investigation – Raman spectrum (RS) and autofluorescence spectrum (AS). “Thus “double” spectroscopy allows, as our experiments show, getting information about tissue structure on the basis of which different types of skin tumor can be identified rather precisely”, – Ivan Bratchenko, associate professor of Department of Laser and Biotechnical Systems of Samara University, asserts.

All three devices work at the department of Oncology of SSMU, clinical site of Samara Regional Clinical Ontology Dispensary and have already been used for several months when oncologists examine patients. With the help of this equipment more than 400 people have already been examined. “The received results give hope that we approach precise diagnostics comparable with morphological research”, – Alexander Moryatov mentioned.

According to Sergey Kozlov diagnostic devices showed high resolution and with time can emerge in the market of medical equipment: “We have few rivalries in Russia and abroad and here we have received better results”.

Samara scholars connect perspectives of their research in diagnostics of skin neoplasm with the increase of its resolution due to the complication of mathematical analysis of spectrum data. Their further plans are to integrate a complex of three devices with fiber-optics to use them for diagnosis of inner located tumors (gastrointestinal tract, lungs, etc.) preserving with this safe for a human being research principle – spectral analysis of tumors.

Tagged with:

About author

Related Articles